BR112014011745A2 - composição farmacêutica, e, processo para a fabricação de uma composição farmacêutica de hidrocortisona - Google Patents

composição farmacêutica, e, processo para a fabricação de uma composição farmacêutica de hidrocortisona

Info

Publication number
BR112014011745A2
BR112014011745A2 BR112014011745A BR112014011745A BR112014011745A2 BR 112014011745 A2 BR112014011745 A2 BR 112014011745A2 BR 112014011745 A BR112014011745 A BR 112014011745A BR 112014011745 A BR112014011745 A BR 112014011745A BR 112014011745 A2 BR112014011745 A2 BR 112014011745A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
manufacture
hydrocortisone
hydrocortisone pharmaceutical
composition
Prior art date
Application number
BR112014011745A
Other languages
English (en)
Other versions
BR112014011745B1 (pt
Inventor
Huatan Hiep
Whitaker Martin
Ross Richard
Original Assignee
Diurnal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diurnal Ltd filed Critical Diurnal Ltd
Publication of BR112014011745A2 publication Critical patent/BR112014011745A2/pt
Publication of BR112014011745B1 publication Critical patent/BR112014011745B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
BR112014011745-4A 2011-11-19 2012-11-19 Composição farmacêutica de hidrocortisona BR112014011745B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1119985.8 2011-11-19
GBGB1119985.8A GB201119985D0 (en) 2011-11-19 2011-11-19 Treatment of adrenal insufficiency
PCT/GB2012/052864 WO2013072707A1 (en) 2011-11-19 2012-11-19 Treatment of adrenal insufficiency

Publications (2)

Publication Number Publication Date
BR112014011745A2 true BR112014011745A2 (pt) 2017-05-30
BR112014011745B1 BR112014011745B1 (pt) 2022-04-05

Family

ID=45475414

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014011745-4A BR112014011745B1 (pt) 2011-11-19 2012-11-19 Composição farmacêutica de hidrocortisona

Country Status (22)

Country Link
US (2) US9675559B2 (pt)
EP (1) EP2780003B1 (pt)
JP (2) JP6228125B2 (pt)
KR (1) KR101995999B1 (pt)
AU (1) AU2012338583B2 (pt)
BR (1) BR112014011745B1 (pt)
CA (1) CA2854717C (pt)
CY (1) CY1123130T1 (pt)
DK (1) DK2780003T3 (pt)
ES (1) ES2782503T3 (pt)
GB (2) GB201119985D0 (pt)
HK (1) HK1194005A1 (pt)
HR (1) HRP20200452T1 (pt)
HU (1) HUE048445T2 (pt)
IL (1) IL232065A (pt)
LT (1) LT2780003T (pt)
PL (1) PL2780003T3 (pt)
PT (1) PT2780003T (pt)
RS (1) RS60132B1 (pt)
SI (1) SI2780003T1 (pt)
WO (1) WO2013072707A1 (pt)
ZA (1) ZA201403462B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201119985D0 (en) 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
GB201308933D0 (en) 2013-05-17 2013-07-03 Diurnal Ltd Paediatric composition
WO2019221483A1 (ko) 2018-05-14 2019-11-21 주식회사 엘지화학 화합물 및 이를 포함하는 유기 발광 소자

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69101291T2 (de) * 1990-08-30 1994-07-07 Senju Pharma Co Zusammensetzung zur kontrollierten Abgabe von Medikamenten.
WO1997025980A1 (en) 1996-01-16 1997-07-24 Advanced Polymer Systems, Inc. Topical delivery of drugs to the lower gastrointestinal tract
DE69721559T2 (de) * 1997-01-06 2003-11-27 Pfizer Geschmacksmaskierte pharmazeutische dosisform mit schneller freisetzung
WO2005102287A2 (en) 2004-04-22 2005-11-03 Duocort Ab Pharmaceutical compositions for acute glucocorticoid therapy
SE0401031D0 (sv) * 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
RU2382637C2 (ru) 2004-04-30 2010-02-27 Астеллас Фарма Инк. Фармацевтическая композиция для перорального введения в форме частиц с рассчитанным временем высвобождения и быстро распадающиеся таблетки, содержащие указанную композицию
US20070281007A1 (en) 2004-08-27 2007-12-06 Jacob Jules S Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs
WO2008126076A2 (en) 2007-04-11 2008-10-23 Perrigo Israel Pharmaceuticals Ltd. Low-dose mometasone formulations
US8298585B2 (en) * 2007-06-06 2012-10-30 Asahi Kasei Chemicals Corporation Cellulose-based fine core particle and process for producing the same
GB0817120D0 (en) 2008-09-19 2008-10-29 Diurnal Ltd Treatment of adrenal insufficiency
NZ595428A (en) 2009-04-07 2013-04-26 Duocourt Pharma Ab Improved glucocorticoid therapy
WO2011032916A1 (de) * 2009-09-17 2011-03-24 Basf Se Mit wirkstoffhaltigen überzügen beschichtete pellets
MX337429B (es) 2010-05-20 2016-03-04 Duocort Pharma Ab Posologia y administracion de composiciones basadas en glucocortticoides.
GB201119985D0 (en) 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
GB201308933D0 (en) 2013-05-17 2013-07-03 Diurnal Ltd Paediatric composition

Also Published As

Publication number Publication date
LT2780003T (lt) 2020-04-27
GB201119985D0 (en) 2012-01-04
BR112014011745B1 (pt) 2022-04-05
US9717740B1 (en) 2017-08-01
HRP20200452T1 (hr) 2020-10-16
CY1123130T1 (el) 2021-10-29
AU2012338583B2 (en) 2017-01-19
RS60132B1 (sr) 2020-05-29
IL232065A (en) 2016-04-21
GB2509663B (en) 2015-01-07
EP2780003B1 (en) 2020-02-19
ES2782503T3 (es) 2020-09-15
US9675559B2 (en) 2017-06-13
JP2014533679A (ja) 2014-12-15
AU2012338583A1 (en) 2014-05-01
IL232065A0 (en) 2014-05-28
DK2780003T3 (da) 2020-03-30
KR101995999B1 (ko) 2019-07-03
GB2509663A (en) 2014-07-09
KR20140108638A (ko) 2014-09-12
ZA201403462B (en) 2016-05-25
SI2780003T1 (sl) 2020-07-31
HUE048445T2 (hu) 2020-08-28
WO2013072707A1 (en) 2013-05-23
CA2854717A1 (en) 2013-05-23
PL2780003T3 (pl) 2020-06-29
EP2780003A1 (en) 2014-09-24
JP6228125B2 (ja) 2017-11-08
US20170202856A1 (en) 2017-07-20
PT2780003T (pt) 2020-04-08
HK1194005A1 (en) 2014-10-10
CA2854717C (en) 2020-12-08
JP2017200942A (ja) 2017-11-09
US20140287052A1 (en) 2014-09-25
GB201407380D0 (en) 2014-06-11

Similar Documents

Publication Publication Date Title
BR112013031916A2 (pt) composição nucicional,uso de uma composição nutricional, processo para a fabricação de uma composição nutricional, e produto
BR112014030071A2 (pt) processo para a fabricação de um vapor de dafd, e, composição
CO7020849A2 (es) Microorganismo recombinante para la producción de metabolitos utiles
BR112014001793A8 (pt) peça de aço soldada, processo para a fabricação de uma peça de aço soldada e uso da peça de aço
BR112015007757A2 (pt) composição, processo para produzir uma composição, molde e uso de uma composição
BR112014000398A2 (pt) poliamida, processo para preparar uma poliamida, artigos e composição
BR112014010023A2 (pt) método in vitro para à produção de uma proteína heterodimérica, e, sequência de nucleotídeo
BR112013012801A2 (pt) método para a produção de um calçado e calçado
BR112014010460A2 (pt) composto, composição farmacêutica, processo para produzir uma composição farmacêutica, método de tratamento, kit e uso de uma composição farmacêutica
BR112014030066A2 (pt) processo para a fabricação de uma composição de dialquil furan-2, 5-dicarboxilato (dafd), e, composição.
BR112012031033A2 (pt) composição de si--g-poliolefina e processo para fazer uma composição de si-g-poliolefina
BR112014012414A2 (pt) processo para a preparação de 5-flúor-1h-pirazolopiridinas substituídas
BR112014004622A8 (pt) processo para a preparação de isocianatos
BR112014006454A2 (pt) composição degeladora , e, processo para produzir uma composição degeladora
BR112013008883A2 (pt) processo para a fabricação de di-hidropteridinonas
BR112013012873A2 (pt) processo para preparar uma n, n-dialquiletanolamina
BR112014013354A2 (pt) processo para a preparação de um polímero, composição, composto, e, formulação
BR112013006230C8 (pt) processo para a preparação de uma n-fenilhidroxilamina substituída
BR112014026565A2 (pt) formulação, uso de uma formulação, e, processo para produzir uma formulação
BR112014014285A2 (pt) composição, e, método para fabricar uma composição
BR112013015874A2 (pt) processo para a separação de uma mistura.
HUP1100244A2 (hu) Gyógyszeripari intermedierek és eljárás elõállításukra
BR112013005986A2 (pt) processo para preparar uma composição derivada de estolídeo e composição derivada de estolídeo
BR112013022930A2 (pt) composição farmacêutica, uso de uma composição farmacêutica, e, processo para produzir uma composição farmacêutica
BR112015000987A2 (pt) processo para a preparação de 5-fluoro-1h-pirazóis

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25G Requested change of headquarter approved

Owner name: DIURNAL LIMITED (GB)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/11/2012, OBSERVADAS AS CONDICOES LEGAIS.